Article (Scientific journals)
Self-medication in persistent rhinitis: overuse of decongestants in half of the patients.
Mehuys, Els; Gevaert, Philippe; Brusselle, Guy et al.
2014In Journal of Allergy and Clinical Immunology: In Practice, 2 (3), p. 313-319
Peer Reviewed verified by ORBi
 

Files


Full Text
Self-Medication in Persistent Rhinitis Overuse of decongestants in half of the patients.pdf
Publisher postprint (493.69 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Community pharmacy; Rhinitis; Self-medication
Abstract :
[en] BACKGROUND: Patients with rhinitis often self-medicate with over-the-counter drugs, however this self-treating population has remained largely unstudied. OBJECTIVE: To characterize individuals self-medicating persistent rhinitis and to determine the prevalence of and risk factors for intranasal decongestant overuse within this population. METHODS: A cross-sectional observational study of individuals self-medicating persistent rhinitis (defined according to the Allergic Rhinitis and its Impact on Asthma guidelines). Participants (n = 895) completed a self-administered questionnaire to assess current symptoms, rhinitis medication, and previous physician diagnosis. Intranasal decongestant overuse was defined as daily use for at least 1 year. RESULTS: The vast majority of subjects (95%) had moderate-to-severe rhinitis. Nasal congestion was the predominant symptom (median visual analog scale, 6.6 cm; interquartile range, 3.4 cm). Sixty-five percent had had their current nasal problems for more than 5 years. Approximately 80% had a physician diagnosis (mainly allergic rhinitis or rhinosinusitis). The prevalence of intranasal decongestant overuse was high (49%), despite the fact that most of the patients (80%) were educated about the limit on duration of use. Use of intranasal glucocorticosteroids was inversely related to being an overuser (odds ratio 0.24 [95% CI, 0.17-0.35]). The risk of intranasal decongestant overuse also was reduced by use of other medications (oral H1 antihistamines and decongestants), use of nasal saline solution, and more symptoms of itchy and/or runny eyes or colored mucus. Risk was increased by a more severely blocked nose, longer duration of symptoms, the presence of sleep disturbance, higher body mass index, and previous advice to limit the duration of intranasal decongestant use. CONCLUSION: Half of the individuals self-medicating persistent rhinitis overused intranasal decongestants, despite the fact that they were educated about the limit on duration of use.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Mehuys, Els
Gevaert, Philippe
Brusselle, Guy
Van Hees, Thierry ;  Université de Liège - ULiège > Département de pharmacie > Pharmacie clinique et pharmacie hospitalière
Adriaens, Els
Christiaens, Thierry
Van Bortel, Luc
Van Tongelen, Inge
Remon, Jean-Paul
Boussery, Koen
Language :
English
Title :
Self-medication in persistent rhinitis: overuse of decongestants in half of the patients.
Publication date :
May 2014
Journal title :
Journal of Allergy and Clinical Immunology: In Practice
ISSN :
2213-2198
eISSN :
2213-2201
Publisher :
Elsevier, Amsterdam, Netherlands
Volume :
2
Issue :
3
Pages :
313-319
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright (c) 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Available on ORBi :
since 13 May 2014

Statistics


Number of views
72 (15 by ULiège)
Number of downloads
3 (3 by ULiège)

Scopus citations®
 
26
Scopus citations®
without self-citations
24
OpenCitations
 
24

Bibliography


Similar publications



Contact ORBi